Trial intelligence / Profile preview

Parent training for children with ADHD stratified by ADHD treatment of affected mothers

2006-001353-96Phase 3Completed

Sponsor
University Hospital Würzburg
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University Hospital Würzburg. Primary endpoint: Child externalizing symptom change. Started Aug 2006; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2006-001353-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001353-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call